Q: What is Sunosi used for?

Sunosi is used to treat excessive daytime sleepiness associated with: narcolepsy obstructive sleep apnea

Q: How does Sunosi work?

Mechanism of Action Sunosi is classified as a dopamine and norepinephrine reuptake inhibitor (DNRI). It is used to help people with narcolepsy or obstructive sleep apnea stay awake during the day. The medication works by affecting two specific neurotransmitters in the brain: Dopamine: A chemical involved in motivation, reward, and wakefulness. Norepinephrine: A chemical that helps the body stay alert and responsive. Under normal conditions, the brain reabsorbs these chemicals after they have sent their signals. Sunosi slows down this reabsorption process, allowing higher levels of dopamine and norepinephrine to remain active in the brain for longer periods. This increased activity helps promote a state of wakefulness. Although the precise mechanism by which Sunosi improves wakefulness is not fully established, its primary action is believed to be the inhibition of these two chemicals.

Q: What are the active ingredients in Sunosi?

The active ingredient in Sunosi is solriamfetol .

Q: What are the side effects of Sunosi?

Common side effects of Sunosi may include: Headache Nausea Decreased appetite and others. Always consult with a healthcare professional about potential side effects.

Q: What drug class is Sunosi?

Sunosi belongs to the norepinephrine-dopamine reuptake inhibitor drug class.

Q: What is the dosage of Sunosi and how do I take it?

How to Take Sunosi Sunosi is taken by mouth, usually once daily when you first wake up. You may take this medication with or without food. Your healthcare provider will determine the appropriate schedule for you. To prevent the medication from interfering with your nighttime sleep, avoid taking Sunosi within nine hours of your planned bedtime. Missed Dose If you miss a dose, take it as soon as you remember. If it is within nine hours of your scheduled bedtime, skip the missed dose and take your next dose at the usual time the following morning. Do not take two doses at the same time.

Q: Is Sunosi safe during pregnancy and breastfeeding?

Pregnancy It is currently unknown if Sunosi will harm an unborn baby. Data from human studies are limited, and animal studies have shown that high doses of the medication may lead to decreased fetal weight or other developmental issues. Because of these uncertainties, Sunosi should only be used during pregnancy if the potential benefit justifies the potential risk to the fetus. A pregnancy exposure registry has been established to monitor the health of individuals who take Sunosi while pregnant. This registry helps healthcare providers collect information about the safety of the medication and its effects on pregnancy outcomes. Breastfeeding It is not known whether Sunosi passes into human breast milk, if it affects milk production, or if it has any effect on a nursing infant. If you are breastfeeding or planning to breastfeed, you should talk to your doctor about the best way to feed your baby while taking this medication. Healthcare providers typically recommend weighing the benefits of breastfeeding against the clinical need for the medication and any potential adverse effects on the breastfed child from the drug or the underlying maternal condition.

Q: What is the FDA approval status of Sunosi?

FDA Approval and Indications The U.S. Food and Drug Administration (FDA) approved Sunosi (solriamfetol) in March 2019. It is indicated to treat excessive daytime sleepiness in adults with narcolepsy or obstructive sleep apnea (OSA). It is important to note that Sunosi is not a treatment for the underlying cause of OSA, and patients should continue using their primary treatments, such as a continuous positive airway pressure (CPAP) machine, while taking this medication. Controlled Substance Status Sunosi is federally regulated as a Schedule IV controlled substance. This classification is assigned to drugs that have a recognized medical use but also carry a potential for abuse, misuse, or the development of physical or psychological dependence. Because of this status, there are specific legal requirements for how the medication is prescribed, stored, and refilled. Safety and Regulatory Warnings The FDA-approved labeling for Sunosi includes warnings regarding its effects on blood pressure and heart rate. Healthcare providers are advised to monitor these vitals before starting the medication and periodically during treatment. Sunosi is contraindicated for use in patients who are currently taking, or have taken within the last 14 days, a monoamine oxidase inhibitor (MAOI) due to the risk of a severe increase in blood pressure.

Question 1

What is Sunosi?

Accepted Answer

Sunosi is a medication that contains the active ingredient solriamfetol. It belongs to a class of drugs known as wakefulness-promoting agents and works by altering the levels of certain natural chemicals in the brain.

These chemicals are involved in regulating the sleep-wake cycle. By affecting these substances, the medication helps to increase wakefulness and improve alertness.

Question 2

What is Sunosi used for?

Accepted Answer

Sunosi is used to treat excessive daytime sleepiness associated with:

narcolepsy
obstructive sleep apnea

Question 3

How does Sunosi work?

Accepted Answer

Mechanism of Action

Sunosi is classified as a dopamine and norepinephrine reuptake inhibitor (DNRI). It is used to help people with narcolepsy or obstructive sleep apnea stay awake during the day.

The medication works by affecting two specific neurotransmitters in the brain:

Dopamine: A chemical involved in motivation, reward, and wakefulness.
Norepinephrine: A chemical that helps the body stay alert and responsive.

Under normal conditions, the brain reabsorbs these chemicals after they have sent their signals. Sunosi slows down this reabsorption process, allowing higher levels of dopamine and norepinephrine to remain active in the brain for longer periods. This increased activity helps promote a state of wakefulness.

Although the precise mechanism by which Sunosi improves wakefulness is not fully established, its primary action is believed to be the inhibition of these two chemicals.

Question 4

What are the active ingredients in Sunosi?

Accepted Answer

The active ingredient in Sunosi is solriamfetol.

Question 5

What are the side effects of Sunosi?

Accepted Answer

Common side effects of Sunosi may include:

Headache
Nausea
Decreased appetite
and others.

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Sunosi?

Accepted Answer

Sunosi belongs to the norepinephrine-dopamine reuptake inhibitor drug class.

Question 7

What is the dosage of Sunosi and how do I take it?

Accepted Answer

How to Take Sunosi

Sunosi is taken by mouth, usually once daily when you first wake up. You may take this medication with or without food. Your healthcare provider will determine the appropriate schedule for you.

To prevent the medication from interfering with your nighttime sleep, avoid taking Sunosi within nine hours of your planned bedtime.

Missed Dose

If you miss a dose, take it as soon as you remember. If it is within nine hours of your scheduled bedtime, skip the missed dose and take your next dose at the usual time the following morning. Do not take two doses at the same time.

Question 8

Is Sunosi safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

It is currently unknown if Sunosi will harm an unborn baby. Data from human studies are limited, and animal studies have shown that high doses of the medication may lead to decreased fetal weight or other developmental issues. Because of these uncertainties, Sunosi should only be used during pregnancy if the potential benefit justifies the potential risk to the fetus.

A pregnancy exposure registry has been established to monitor the health of individuals who take Sunosi while pregnant. This registry helps healthcare providers collect information about the safety of the medication and its effects on pregnancy outcomes.

Breastfeeding

It is not known whether Sunosi passes into human breast milk, if it affects milk production, or if it has any effect on a nursing infant. If you are breastfeeding or planning to breastfeed, you should talk to your doctor about the best way to feed your baby while taking this medication.

Healthcare providers typically recommend weighing the benefits of breastfeeding against the clinical need for the medication and any potential adverse effects on the breastfed child from the drug or the underlying maternal condition.

Question 9

What forms and strengths does Sunosi come in?

Accepted Answer

Sunosi is supplied as an oral tablet. It is intended to be taken by mouth, typically once daily upon awakening. The tablets can be taken with or without food.

Question 10

What is the FDA approval status of Sunosi?

Accepted Answer

FDA Approval and Indications

The U.S. Food and Drug Administration (FDA) approved Sunosi (solriamfetol) in March 2019. It is indicated to treat excessive daytime sleepiness in adults with narcolepsy or obstructive sleep apnea (OSA). It is important to note that Sunosi is not a treatment for the underlying cause of OSA, and patients should continue using their primary treatments, such as a continuous positive airway pressure (CPAP) machine, while taking this medication.

Controlled Substance Status

Sunosi is federally regulated as a Schedule IV controlled substance. This classification is assigned to drugs that have a recognized medical use but also carry a potential for abuse, misuse, or the development of physical or psychological dependence. Because of this status, there are specific legal requirements for how the medication is prescribed, stored, and refilled.

Safety and Regulatory Warnings

The FDA-approved labeling for Sunosi includes warnings regarding its effects on blood pressure and heart rate. Healthcare providers are advised to monitor these vitals before starting the medication and periodically during treatment. Sunosi is contraindicated for use in patients who are currently taking, or have taken within the last 14 days, a monoamine oxidase inhibitor (MAOI) due to the risk of a severe increase in blood pressure.

Question 11

What should I know about Sunosi and cost?

Accepted Answer

Brand-Name Status

Sunosi is currently available only as a brand-name medication. There is no generic version of solriamfetol available at this time, which generally results in higher out-of-pocket costs compared to generic drugs.

Financial Assistance

Patients may be able to lower their costs by using a manufacturer savings card. These programs are typically available to eligible patients with commercial insurance. It is recommended to check the manufacturer's website or consult with a pharmacist to determine eligibility for available discounts or patient assistance programs.

Insurance and Pharmacy Factors

The amount you pay for Sunosi is largely determined by your insurance provider's formulary and your specific plan's copayment or deductible requirements. Because it is a brand-name drug, some insurance plans may require prior authorization before covering the medication. Additionally, retail prices can vary between different pharmacies, so comparison shopping may be beneficial.

Sunosi

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Sunosi

Hospitals.net Disclosure